MicroRNAs in the ionizing radiation response and in radiotherapy

Current Opinion in Genetics and Development

Volumn 23, Issue 1, 2013, Pages 12-19

  Metheetrairut, Chanatip ^a   Slack, Frank J ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; ATM PROTEIN; DICER; EXTRACELLULAR SUPEROXIDE DISMUTASE; HISTONE H2AX; K RAS PROTEIN; LET 7A; LET 7B; LET 7G; MICRORNA; MICRORNA 101; MICRORNA 155; MICRORNA 21; MICRORNA 34A; MICRORNA 99; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

AGO2 GENE; CANCER RADIOTHERAPY; CDC25A GENE; CELL CYCLE CHECKPOINT; DICER GENE; DNA END JOINING REPAIR; DOUBLE STRANDED DNA BREAK; DROSHA GENE; GAMMA IRRADIATION; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; H2AX GENE; HISTONE MODIFICATION; HUMAN; INTRACELLULAR SIGNALING; IONIZING RADIATION; NONHUMAN; ONCOGENE K RAS; ONCOGENE MYC; ONCOGENE RAS; PHOTON THERAPY; PRIORITY JOURNAL; PROTEIN RNA BINDING; RADIATION PROTECTION; RADIATION RESPONSE; RADIOSENSITIZATION; REVIEW; SMARCA5 GENE; SNF2H GENE; TUMOR SUPPRESSOR GENE;

CELL LINE, TUMOR; DNA BREAKS, DOUBLE-STRANDED; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; NEOPLASMS; RADIATION TOLERANCE; RADIATION, IONIZING; TRANSCRIPTION FACTORS;

EID: 84877922897     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2013.01.002     Document Type: Review

References (70)

1. Willers H., Held K.D. Introduction to clinical radiation biology. Hematol Oncol Clin North Am 2006, 20:1-24. 10.1016/j.hoc.2006.01.007.
2. Li L., Story M., Legerski R.J. Cellular responses to ionizing radiation damage. Int J Radiat Oncol Biol Phys 2001, 49:1157-1162.
3. Steel G.G. From targets to genes: a brief history of radiosensitivity. Phys Med Biol 1996, 41:205-222.
4. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355. 10.1038/nature02871.
5. Jackson R.J., Standart N. How do microRNAs regulate gene expression?. Sci STKE 2007 2007, 367. re1 doi:10.1126/stkere1.
6. Kasinski A.L., Slack F.J. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011, 11:849-864. 10.1038/nrc3166.
7. Bader A.G., Brown D., Stoudemire J., Lammers P. Developing therapeutic microRNAs for cancer. Gene Ther 2011, 18:1121-1126. 10.1038/gt.2011.79.
8. Zhou J., Liu J., Cheng C.J., Patel T.R., Weller C.E., Piepmeier J.M., Jiang Z., Saltzman W.M. Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery. Nat Mater 2011, 11:82-90. 10.1038/nmat3187.
9. Babar I.A., Cheng C.J., Booth C.J., Liang X., Weidhaas J.B., Saltzman W.M., Slack F.J. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci U S A 2012, 109:E1695-E1704. 10.1073/pnas.1201516109.
10. Woodrow K.A., Cu Y., Booth C.J., Saucier-Sawyer J.K., Wood M.J., Saltzman W.M. Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nat Mater 2009, 8:526-533. 10.1038/nmat2444.
11. Bussing I., Slack F.J., Grosshans H. let-7 microRNAs in development, stem cells and cancer. Trends Mol Med 2008, 14:400-409. 10.1016/j.molmed.2008.07.001.
12. Kasinski A.L., Slack F.J. Potential microRNA therapies targeting Ras, NFkappaB and p53 signaling. Curr Opin Mol Ther 2010, 12:147-157.
13. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K.L., Brown D., Slack F.J. RAS is regulated by the let-7 microRNA family. Cell 2005, 120:635-647. 10.1016/j.cell.2005.01.014.
14. Dent P., Yacoub A., Fisher P.B., Hagan M.P., Grant S. MAPK pathways in radiation responses. Oncogene 2003, 22:5885-5896. 10.1038/sj.onc.1206701.
15. Abou-El-Ardat K., Monsieurs P., Anastasov N., Atkinson M., Derradji H., De Meyer T., Bekaert S., Van Criekinge W., Baatout S. Low dose irradiation of thyroid cells reveals a unique transcriptomic and epigenetic signature in RET/PTC-positive cells. Mutat Res 2012, 731:27-40. 10.1016/j.mrfmmm.2011.10.006.
16. Arora H., Qureshi R., Jin S., Park A.K., Park W.Y. miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFkappaB1. Exp Mol Med 2011, 43:298-304. 10.3858/emm.2011.43.5.031.
17. Chaudhry M.A., Omaruddin R.A., Kreger B., de Toledo S.M., Azzam E.I. Micro RNA responses to chronic or acute exposures to low dose ionizing radiation. Mol Biol Rep 2012, 39:7549-7558. 10.1007/s11033-012-1589-9.
18. Dickey J.S., Zemp F.J., Martin O.A., Kovalchuk O. The role of miRNA in the direct and indirect effects of ionizing radiation. Radiat Environ Biophys 2011, 50:491-499. 10.1007/s00411-011-0386-5.
19. Girardi C., De Pitta C., Casara S., Sales G., Lanfranchi G., Celotti L., Mognato M. Analysis of miRNA and mRNA expression profiles highlights alterations in ionizing radiation response of human lymphocytes under modeled microgravity. PLoS One 2012, 7:e31293. 10.1371/journal.pone.0031293.
20. Nikiforova M.N., Gandhi M., Kelly L., Nikiforov Y.E. MicroRNA dysregulation in human thyroid cells following exposure to ionizing radiation. Thyroid 2011, 21:261-266. 10.1089/thy.2010.0376.
21. Simone N.L., Soule B.P., Ly D., Saleh A.D., Savage J.E., Degraff W., Cook J., Harris C.C., Gius D., Mitchell J.B. Ionizing radiation-induced oxidative stress alters miRNA expression. PLoS One 2009, 4:e6377. 10.1371/journal.pone.0006377.
22. Chaudhry M.A., Sachdeva H., Omaruddin R.A. Radiation-induced micro-RNA modulation in glioblastoma cells differing in DNA-repair pathways. DNA Cell Biol 2010, 29:553-561. 10.1089/dna.2009.0978.
23. Templin T., Paul S., Amundson S.A., Young E.F., Barker C.A., Wolden S.L., Smilenov L.B. Radiation-induced micro-RNA expression changes in peripheral blood cells of radiotherapy patients. Int J Radiat Oncol Biol Phys 2011, 80:549-557. 10.1016/j.ijrobp.2010.12.061.
24. Chen G., Zhu W., Shi D., Lv L., Zhang C., Liu P., Hu W. MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2. Oncol Rep 2010, 23:997-1003.
25. Wagner-Ecker M., Schwager C., Wirkner U., Abdollahi A., Huber P.E. MicroRNA expression after ionizing radiation in human endothelial cells. Radiat Oncol 2010, 5:25. 10.1186/1748-717X-5-25.
26. Weidhaas J.B., Babar I., Nallur S.M., Trang P., Roush S., Boehm M., Gillespie E., Slack F.J. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 2007, 67:11111-11116. 10.1158/0008-5472.CAN-07-2858.
27. Viswanathan S.R., Daley G.Q., Gregory R.I. Selective blockade of microRNA processing by Lin28. Science 2008, 320:97-100.
28. Saleh A.D., Savage J.E., Cao L., Soule B.P., Ly D., DeGraff W., Harris C.C., Mitchell J.B., Simone N.L. Cellular stress induced alterations in microRNA let-7a and let-7b expression are dependent on p53. PLoS One 2011, 6:e24429. 10.1371/journal.pone.0024429.
29. Lu C., El-Deiry W.S. Targeting p53 for enhanced radio- and chemo-sensitivity. Apoptosis 2009, 14:597-606. 10.1007/s10495-009-0330-1.
30. Hermeking H. p53 enters the microRNA world. Cancer Cell 2007, 12:414-418. 10.1016/j.ccr.2007.10.028.
31. Josson S., Sung S.Y., Lao K., Chung L.W., Johnstone P.A. Radiation modulation of microRNA in prostate cancer cell lines. Prostate 2008, 68:1599-1606. 10.1002/pros.20827.
32. Kato M., Paranjape T., Muller R.U., Nallur S., Gillespie E., Keane K., Esquela-Kerscher A., Weidhaas J.B., Slack F.J. The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene 2009, 28:2419-2424. 10.1038/onc.2009.106.
33. Buscaglia L.E., Li Y. Apoptosis and the target genes of microRNA-21. Chin J Cancer 2011, 30:371-380.
34. Vincenti S., Brillante N., Lanza V., Bozzoni I., Presutti C., Chiani F., Etna M.P., Negri R. HUVEC respond to radiation by inducing the expression of pro-angiogenic microRNAs. Radiat Res 2011, 175:535-546. 10.1667/RR2200.1.
35. Mueller A.C., Sun D., Dutta A. The miR-99 family regulates the DNA damage response through its target SNF2H. Oncogene 2012, 10.1038/onc.2012.131.
36. Shi Y., Zhang X., Tang X., Wang P., Wang H., Wang Y. MiR-21 is continually elevated long-term in the brain after exposure to ionizing radiation. Radiat Res 2012, 177:124-128.
37. Oh J.S., Kim J.J., Byun J.Y., Kim I.A. Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. Int J Radiat Oncol Biol Phys 2010, 76:5-8. 10.1016/j.ijrobp.2009.08.028.
38. Jeong S.H., Wu H.G., Park W.Y. LIN28B confers radio-resistance through the posttranscriptional control of KRAS. Exp Mol Med 2009, 41:912-918. 10.3858/emm.2009.41.12.097.
39. Balca-Silva J., Sousa Neves S., Goncalves A.C., Abrantes A.M., Casalta-Lopes J., Botelho M.F., Sarmento-Ribeiro A.B., Silva H.C. Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines. Anticancer Res 2012, 32:1603-1609.
40. Li Y., Zhao S., Zhen Y., Li Q., Teng L., Asai A., Kawamoto K. A miR-21 inhibitor enhances apoptosis and reduces G(2)-M accumulation induced by ionizing radiation in human glioblastoma U251 cells. Brain Tumor Pathol 2011, 28:209-214. 10.1007/s10014-011-0037-1.
41. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011, 39:D152-D157. 10.1093/nar/gkq1027.
42. Aqeilan R.I., Calin G.A., Croce C.M. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 2010, 17:215-220. 10.1038/cdd.2009.69.
43. Mendell J.T. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008, 133:217-222. 10.1016/j.cell.2008.04.001.
44. Kraemer A., Anastasov N., Angermeier M., Winkler K., Atkinson M.J., Moertl S. MicroRNA-mediated processes are essential for the cellular radiation response. Radiat Res 2011, 176:575-586.
45. Surova O., Akbar N.S., Zhivotovsky B. Knock-down of core proteins regulating microRNA biogenesis has no effect on sensitivity of lung cancer cells to ionizing radiation. PLoS One 2012, 7:e33134. 10.1371/journal.pone.0033134.
46. Francia S., Michelini F., Saxena A., Tang D., de Hoon M., Anelli V., Mione M., Carninci P., d'Adda di Fagagna F. Site-specific DICER and DROSHA RNA products control the DNA-damage response. Nature 2012, 488:231-235. 10.1038/nature11179.
47. Lavin M.F. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 2008, 9:759-769. 10.1038/nrm2514.
48. Zhang X., Wan G., Berger F.G., He X., Lu X. The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol Cell 2011, 41:371-383. 10.1016/j.molcel.2011.01.020.
49. Hu H., Du L., Nagabayashi G., Seeger R.C., Gatti R.A. ATM is down-regulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci U S A 2010, 107:1506-1511. 10.1073/pnas.0907763107.
50. Yan D., Ng W.L., Zhang X., Wang P., Zhang Z., Mo Y.Y., Mao H., Hao C., Olson J.J., Curran W.J., et al. Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. PLoS One 2010, 5:e11397. 10.1371/journal.pone.0011397.
51. Ng W.L., Yan D., Zhang X., Mo Y.Y., Wang Y. Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J. DNA Repair (Amst) 2010, 9:1170-1175. 10.1016/j.dnarep.2010.08.007.
52. Song L., Lin C., Wu Z., Gong H., Zeng Y., Wu J., Li M., Li J. miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase. PLoS One 2011, 6:e25454. 10.1371/journal.pone.0025454.
53. van Attikum H., Gasser S.M. Crosstalk between histone modifications during the DNA damage response. Trends Cell Biol 2009, 19:207-217. 10.1016/j.tcb.2009.03.001.
54. Lal A., Pan Y., Navarro F., Dykxhoorn D.M., Moreau L., Meire E., Bentwich Z., Lieberman J., Chowdhury D. miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat Struct Mol Biol 2009, 16:492-498. 10.1038/nsmb.1589.
55. Wang Y., Huang J.W., Li M., Cavenee W.K., Mitchell P.S., Zhou X., Tewari M., Furnari F.B., Taniguchi T. MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression. Mol Cancer Res 2011, 9:1100-1111. 10.1158/1541-7786.MCR-11-0007.
56. Lan L., Ui A., Nakajima S., Hatakeyama K., Hoshi M., Watanabe R., Janicki S.M., Ogiwara H., Kohno T., Kanno S., et al. The ACF1 complex is required for DNA double-strand break repair in human cells. Mol Cell 2010, 40:976-987. 10.1016/j.molcel.2010.12.003.
57. Sun D., Lee Y.S., Malhotra A., Kim H.K., Matecic M., Evans C., Jensen R.V., Moskaluk C.A., Dutta A. miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. Cancer Res 2011, 71:1313-1324. 10.1158/0008-5472.CAN-10-1031.
58. Medema R.H., Macurek L. Checkpoint control and cancer. Oncogene 2012, 31:2601-2613. 10.1038/onc.2011.451.
59. Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 2012, 12:613-626. 10.1038/nrc3318.
60. Wang P., Zou F., Zhang X., Li H., Dulak A., Tomko R.J., Lazo J.S., Wang Z., Zhang L., Yu J. microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res 2009, 69:8157-8165. 10.1158/0008-5472.CAN-09-1996.
61. Johnson C.D., Esquela-Kerscher A., Stefani G., Byrom M., Kelnar K., Ovcharenko D., Wilson M., Wang X., Shelton J., Shingara J., et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007, 67:7713-7722. 10.1158/0008-5472.CAN-07-1083.
62. Moskwa P., Buffa F.M., Pan Y., Panchakshari R., Gottipati P., Muschel R.J., Beech J., Kulshrestha R., Abdelmohsen K., Weinstock D.M., et al. miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell 2011, 41:210-220. 10.1016/j.molcel.2010.12.005.
63. Chang S., Wang R.H., Akagi K., Kim K.A., Martin B.K., Cavallone L., Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Haines D.C., Basik M., Mai P., et al. Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med 2011, 17:1275-1282. 10.1038/nm.2459.
64. Babar I.A., Czochor J., Steinmetz A., Weidhaas J.B., Glazer P.M., Slack F.J. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther 2011, 12:908-914. 10.4161/cbt.12.10.17681.
65. Chen S., Wang H., Ng W.L., Curran W.J., Wang Y. Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level. Int J Radiat Oncol Biol Phys 2011, 81:1524-1529. 10.1016/j.ijrobp.2011.05.031.
66. Zhang X., Ng W.L., Wang P., Tian L., Werner E., Wang H., Doetsch P., Wang Y. MicroRNA-21 modulates the levels of reactive oxygen species levels by targeting SOD3 and TNF. Cancer Res 2012, 10.1158/0008-5472.CAN-12-0639.
67. Li B., Shi X.B., Nori D., Chao C.K., Chen A.M., Valicenti R., White Rde V. Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells. Prostate 2011, 71:567-574. 10.1002/pros.21272.
68. Lee K.M., Choi E.J., Kim I.A. microRNA-7 increases radiosensitivity of human cancer cells with activated EGFR-associated signaling. Radiother Oncol 2011, 101:171-176. 10.1016/j.radonc.2011.05.050.
69. Jiang P., Rao E.Y., Meng N., Zhao Y., Wang J.J. MicroRNA-17-92 significantly enhances radioresistance in human mantle cell lymphoma cells. Radiat Oncol 2010, 5:100. 10.1186/1748-717X-5-100.
70. Chun-Zhi Z., Lei H., An-Ling Z., Yan-Chao F., Xiao Y., Guang-Xiu W., Zhi-Fan J., Pei-Yu P., Qing-Yu Z., Chun-Sheng K. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 2010, 10:367. 10.1186/1471-2407-10-367.